Sennosides and Docusate Sodium
NDC 76420-918, Sennosides, Docusate Sodium, tablet, from Asclemed USA, Inc..
- Product NDC
- 76420-918
- Status
- Listed
- Labeler
- Asclemed USA, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/76420-918 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SENNOSIDES8.6 mg/1
- DOCUSATE SODIUM50 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 76420-918-01 | 76420091801 | 100 TABLET in 1 BOTTLE (76420-918-01) |
| 76420-918-30 | 76420091830 | 30 TABLET in 1 BOTTLE (76420-918-30) |
| 76420-918-60 | 76420091860 | 60 TABLET in 1 BOTTLE (76420-918-60) |
| 76420-918-90 | 76420091890 | 90 TABLET in 1 BOTTLE (76420-918-90) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 76420-918 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/76420-918 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 76420-918. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.